Splenic marginal zone lymphoma: disease features and management

E Matutes - Expert review of hematology, 2013 - Taylor & Francis
Splenic marginal zone lymphoma (SMZL) is a lymphoma recognized as a distinct entity in
the WHO classification of the lymphoid tumors. SMZL probably results from the expansion of …

Treatment of splenic marginal zone lymphoma

C Kalpadakis, GA Pangalis, MK Angelopoulou… - Best Practice & …, 2017 - Elsevier
Splenic marginal zone lymphoma (SMZL) is a distinct lymphoma entity characterized by an
indolent clinical course and prolonged survival. Treatment is not standardized, since there …

Splenic marginal zone lymphoma: current knowledge and future directions

MD Catherine Thieblemont, ME Noguera… - …, 2012 - search.proquest.com
Splenic marginal zone lymphoma (SMZL), along with extranodal marginal zone lymphoma
of mucosa-associated lymphoid tissue (MALT lymphoma) and nodal marginal zone …

Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?

C Kalpadakis, GA Pangalis… - Leukemia & …, 2014 - Taylor & Francis
Splenic marginal zone lymphoma (SMZL) is a rare chronic B-cell lymphoproliferative
disorder recognized as a distinct entity in the World Health Organization (WHO) …

Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges

TS Santos, RS Tavares, DLC Farias - Revista brasileira de …, 2017 - SciELO Brasil
Splenic marginal zone lymphoma (SMZL) is a low-grade B-cell non-Hodgkin's lymphoma
characterized by massive splenomegaly, moderate lymphocytosis with or without villous …

Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab

M Bennett, GP Schechter - Seminars in hematology, 2010 - Elsevier
Splenic marginal zone lymphoma (SMZL) is an uncommon indolent B-cell lymphoma
causing marked splenic enlargement with CD20-rich lymphoma cells infiltrating blood and …

Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era

AG Starr, PF Caimi, PF Fu, MR Massoud… - …, 2017 - Taylor & Francis
Objectives and methods: Splenic marginal zone lymphoma (SMZL) is a rare non-Hodgkin
lymphoma. We sought to identify prognostic factors and define outcomes in a cohort of 64 …

[HTML][HTML] Splenic Marginal Zone Lymphoma: French Registries Population-Based Treatment and Survival Analyses (2002-2014)

M Maynadie, S Gauthier, M Mounier, C Bommier… - Blood, 2020 - Elsevier
Background. Splenic Marginal Zone Lymphoma (SMZL) is a rare indolent B-cell lymphoma
characterized by a massive splenomegaly and a moderate lymphocytosis. There is no …

Splenic marginal zone lymphoma

V Franco, AM Florena, E Iannitto - Blood, The Journal of the …, 2003 - ashpublications.org
Splenic marginal zone lymphoma (SMZL) is a specific low-grade small B-cell lymphoma that
is incorporated in the World Health Organization classification. Characteristic features are …

Splenic marginal zone lymphoma: a review of the clinical presentation, pathology, molecular biology, and management

L Sena Teixeira Mendes, MQ Du… - Blood and Lymphatic …, 2014 - Taylor & Francis
Splenic marginal zone lymphoma is a distinct low grade B-cell lymphoma primarily occurring
in the spleen and separate from nodal marginal zone lymphoma and extranodal marginal …